SynCore Biotechnology Co.,Ltd (4192.TWO)
TWD 30.0
(0.0%)
TWD 30.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -17.72 Million TWD | 87.89% |
| 2022 | -146.32 Million TWD | 63.79% |
| 2021 | -404.13 Million TWD | -19.19% |
| 2020 | -339.06 Million TWD | 17.72% |
| 2019 | -353.36 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -8.84 Million TWD | -1.1% |
| 2024 Q1 | -8.75 Million TWD | -118.94% |
| 2023 Q4 | 46.2 Million TWD | 286.4% |
| 2023 FY | - TWD | 87.89% |
| 2023 Q2 | -21.34 Million TWD | -19.86% |
| 2023 Q1 | -17.8 Million TWD | 77.8% |
| 2023 Q3 | -24.78 Million TWD | -16.16% |
| 2022 FY | - TWD | 63.79% |
| 2022 Q4 | -80.19 Million TWD | 0.0% |
| 2021 FY | - TWD | -19.19% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 104.503% |
| Level Biotechnology Inc. | 98.7 Million TWD | 117.959% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 29.751% |
| GlycoNex Incorporation | -126.82 Million TWD | 86.023% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 87.664% |
| OBI Pharma, Inc. | -855.08 Million TWD | 97.927% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 181.275% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 82.892% |
| Visgeneer Inc. | 973 Thousand TWD | 1921.788% |
| Neith Corporation | -33.61 Million TWD | 47.26% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 92.18% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 98.211% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -920.495% |
| Enimmune corporation | -228.96 Million TWD | 92.258% |
| TaiRx, Inc. | -208.64 Million TWD | 91.504% |
| CHO Pharma, Inc. | -277.73 Million TWD | 93.618% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 123.985% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 125.637% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 102.704% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 150.881% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 32.601% |
| RBC Bioscience Corporation | 36.54 Million TWD | 148.502% |
| NaviFUS Corp. | -55.79 Million TWD | 68.23% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 97.403% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 46.295% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 67.721% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 60.379% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 71.566% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 77.862% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 84.328% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 117.755% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 71.177% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 98.346% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 61.669% |
| AP Biosciences Inc | -325.51 Million TWD | 94.554% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 101.893% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 104.089% |
| EirGenix Inc. | -664.4 Million TWD | 97.332% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 160.851% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 94.779% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 60.566% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 75.42% |
| VBI | -6.97 Million TWD | -154.246% |
| BiOptic Inc. | 65.03 Million TWD | 127.255% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -6.796% |
| Sinew Pharma Inc. | -163.63 Million TWD | 89.167% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 109.213% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 98.303% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 50.55% |
| Intech Biopharm Corporation | -219.58 Million TWD | 91.927% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 97.371% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 88.98% |
| TCI GENE Inc. | 25.98 Million TWD | 168.227% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 83.978% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 93.754% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 87.856% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 227.986% |
| PharmaEngine, Inc. | 347.3 Million TWD | 105.104% |
| Savior Lifetec Corporation | 219.6 Million TWD | 108.072% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 110.292% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 80.85% |
| Acepodia, Inc. | -764.51 Million TWD | 97.681% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 96.147% |